Celgene Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2012
For the full year, the company reported total revenues of $5,506,713,000 compared to $4,842,070,000 a year ago. Operating income was $1,746,442,000 compared to $1,442,753,000 a year ago. Income before income taxes was $1,681,491,000 compared to $1,419,522,000 a year ago. Net income attributable to company was $1,456,180,000 or $3.30 per diluted share compared to $1,318,150,000 or $2.85 per diluted share a year ago. Adjusted net income attributable to company was $2,162,486,000 or $4.91 per diluted share compared to $1,752,908,000 or $3.79 per diluted share a year ago. Operations generated cash flow of $2,031 million for 2012, an increase of 12% compared to 2011.